All terms in GO
| Label | Id | Description |
|---|---|---|
| positive regulation of interferon-alpha production | GO_0032727 | [Any process that activates or increases the frequency, rate, or extent of interferon-alpha production.] |
| positive regulation of translation in response to nitrogen starvation | GO_0070323 | [Any process that activates or increases the frequency, rate or extent of translation as a result of a stimulus indicating deprivation of nitrogen.] |
| regulation of interferon-beta biosynthetic process | GO_0045357 | [Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interferon-beta.] |
| regulation of interferon-beta production | GO_0032648 | [Any process that modulates the frequency, rate, or extent of interferon-beta production.] |
| interferon-beta biosynthetic process | GO_0045350 | [The chemical reactions and pathways resulting in the formation of interferon-beta.] |
| thyroid hormone binding | GO_0070324 | [Interacting selectively and non-covalently with thyroxine (T4) or triiodothyronine (T3), tyrosine-based hormones produced by the thyroid gland.] |
| negative regulation of interferon-beta biosynthetic process | GO_0045358 | [Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interferon-beta.] |
| negative regulation of interferon-beta production | GO_0032688 | [Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-beta production.] |
| positive regulation of interferon-beta biosynthetic process | GO_0045359 | [Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interferon-beta.] |
| positive regulation of interferon-beta production | GO_0032728 | [Any process that activates or increases the frequency, rate, or extent of interferon-beta production.] |
| very-low-density lipoprotein particle receptor binding | GO_0070326 | [Interacting selectively and non-covalently with a very-low-density lipoprotein receptor.] |
| thyroid hormone transport | GO_0070327 | [The directed movement of thyroid hormone into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.] |
| triglyceride homeostasis | GO_0070328 | [Any process involved in the maintenance of an internal steady state of triglyceride within an organism or cell.] |
| tRNA seleno-modification | GO_0070329 | [The substitution of a selenium atom for a sulfur atom in a ribonucleotide in a tRNA molecule.] |
| type I interferon biosynthetic process | GO_0045351 | [The chemical reactions and pathways resulting in the formation of any type I interferon. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.] |
| interferon-beta production | GO_0032608 | [The appearance of interferon-beta due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.] |
| type I interferon production | GO_0032606 | [The appearance of type I interferon due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.] |
| coronary artery morphogenesis | GO_0060982 | [The process in which the anatomical structures of coronary arteries are generated and organized. Coronary arteries are blood vessels that transport blood to the heart muscle.] |
| coronary vasculature morphogenesis | GO_0060977 | [The process in which the anatomical structures of blood vessels of the heart are generated and organized. The blood vessel is the vasculature carrying blood.] |
| epicardium-derived cardiac vascular smooth muscle cell differentiation | GO_0060983 | [The process in which a relatively unspecialized cell derived from the epicardium acquires specialized features of a cardiac vascular smooth muscle cell. A cardiac vascular smooth muscle cell covers the heart vasculature and lacks transverse striations in its constituent fibers.] |